The eye-opening study “Efficacy, Tolerance, and Safety of a Novel Botanical Anti-Inflammatory Moisturizer in Rosacea: Results From a Double-Blinded, Randomized Controlled Trial” has just been published in an internationally respected peer-reviewed journal. 

In this landmark randomized, controlled, double-blind clinical trial, Crescel’s therapeutic benefits were dramatically superior to standard-of-care prescription rosacea therapy. Focused on key clinical measures, Crescel reduced redness by 54% vs. 23% and inflammatory lesions by 74% vs. 17%. Also exceptional in the context of rosacea is that these outstanding, statistically significant improvements occurred without any irritation or other adverse effects. These results are breaking critical new ground in rosacea care. 

Please review the article, published in the highly respected and internationally recognized Journal of Cosmetic Dermatology and authored by a world-renowned dermatologist. It describes Crescel and details these landmark results. A link to the Abstract in PubMed is also provided.

https://onlinelibrary.wiley.com/doi/10.1111/jocd.70910 
https://pubmed.ncbi.nlm.nih.gov/42163060/